Status:
RECRUITING
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Pancreatic Neoplasms
Pancreas Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The aims of this study are to determine the natural history of pancreatic cysts and to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous...
Detailed Description
Pancreatic cysts are increasingly recognized as incidental lesions due to the widespread use of cross-sectional imaging techniques such as CT and MRI. Twenty percent of all pancreatic cysts are non-in...
Eligibility Criteria
Inclusion
- Adult patients age 18 years and older
- Referred for assessment of a pancreatic cyst.
Exclusion
- Medically ill patients with American Society of Anesthesiologists class 4 or greater.
- Inability to provide informed consent.
- Pregnancy or lactation.
Key Trial Info
Start Date :
July 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2036
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04473794
Start Date
July 20 2022
End Date
August 1 2036
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287